()
 
 

Overview

Oncolytics Biotech Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human cancers. Headquartered in Calgary, Alberta, Canada, the Company was formed in 1998 to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer. www.oncolyticsbiotech.com


Contact Information

1167 Kensington Crescent NW
Suite 210
Calgary, AB T2N1X7

tel:
fax:
http://www.oncolyticsbiotech.com

,  



Investor Relations


Mr. Douglas Ball
tel:
fax:
e-mail: info@oncolyticsbiotech.com




Stock

Exchange: TSX
Industry: Industrial
Market Cap: $79.7M




 
The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.